Analytical Data
-
基因名
P2
- Application
-
别名
Protein P2
-
种属
Pseudomonas phage phi6
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P11124
-
表达区间
310-485aa
-
分子量
27.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
P2 recombinant proteins have garnered significant attention in the field of molecular biology and biotechnology due to their crucial roles in various biological processes and their applications in therapeutic development. The P2 protein, derived from specific pathogens or organisms, often serves as a model for studying protein structure, function, and interaction within cellular systems. Research into P2 recombinant proteins typically focuses on their expression, purification, and characterization, as well as their potential uses in vaccine development, where they can elicit immune responses without the risks associated with live pathogens. Additionally, P2 proteins are instrumental in understanding the mechanisms of diseases, thereby aiding in the discovery of novel drug targets. Advances in genetic engineering and recombinant DNA technology have facilitated the production of P2 proteins in host organisms, allowing for large-scale production and detailed studies. As a result, P2 recombinant protein research is pivotal in enhancing our understanding of biological systems and advancing medical interventions, particularly in combating infectious diseases and improving vaccine efficacy. The ongoing exploration of P2 proteins continues to promise innovations in therapeutic applications and diagnostic tools, marking them as an important focus in contemporary biomedical research.
